[Treatment of enuresis with Noveril].
The authors present their observations on treatment with Noveril of nocturnal enuresis in 49 children aged from 6 to 16 years. The drug is a derivative of dibenzodiazepine belonging to the group of thymoleptic agents with an action similar to that of imipramine. Noveril was given in doses from 20 to 100 mg daily during 3 to 9 weeks. In the final evaluation of the drug the frequency of enuresis before, during and after treatment was taken into account. In 25 cases an improvement was observed, usually in psychogenic nocturnal enuresis. Side effects included oral dryness, headaches and dizziness, and sleep disturbances observed in 4 cases. The tolerance of the drug was good. Noveril has a favourable effect in children with nocturnal enuresis, particularly of psychogenic origin.
D000293:Adolescent; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines; D002648:Child; D003984:Dibenzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D004775:Enuresis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D012893:Sleep Wake Disorders / Q000139:chemically induced
D014151:Anti-Anxiety Agents; D003984:Dibenzazepines; D001569:Benzodiazepines
Spostrzezenia nad stosowaniem noverilu w moczeniu nocnym